Stefan Boeck und Volker Heinemann - Info zur Person

(1 - 12 von 16

)

History of Changes for Study: NCT

clinicaltrials.gov

Central Contact Backup: Stefan Boeck, MD Telephone: + muenchen.de. Study Officials: Volker Heinemann, MD

American Journal of Surgery - Vol n° 3 - EM consulte

www.em-consulte.com

... Christians, Martin K. Angele, Axel Kleespies, Martin E. Eichhorn, Ivan Ischenko, Stefan Boeck, Volker Heinemann, Karl-Walter Jauch, Christiane J. Bruns.

Long-term Progression-free Survival in A Metastatic Pancreatic Cancer...

iv.iiarjournals.org

STEFAN BOECK, MICHAEL HAAS, STEPHAN KRUGER and VOLKER HEINEMANN. In Vivo November 2014, 28 (6) ;. STEFAN BOECK. Department of Internal Medicine III ...

Clinical relevance of EGFR- and KRAS-status in Colon EQA Scheme

kras.eqascheme.org

Volker Heinemann *, Sebastian Stintzing, Thomas Kirchner, Stefan Boeck, Andreas Jung. Department of Hematology/Oncology, Klinikum Grosshadern, ...

Use of PERCIST for Prediction of Progression-Free and Overall...

jnm.snmjournals.org

Marlies Michl,; Sebastian Lehner,; Philipp M. Paprottka,; Harun Ilhan,; Peter Bartenstein,,; Volker Heinemann,,; Stefan Boeck,,; Nathalie L.

National Institutes of Health (NIH) (.gov)

pubmed.ncbi.nlm.nih.gov

von S Boeck · · Zitiert von: 223 — Stefan Boeck , Petra Stieber, Stefan Holdenrieder, Ralf Wilkowski, Volker Heinemann ... Affiliation. 1 Department of Internal Medicine III, Klinikum Grosshadern, ...

Anti–Epidermal Growth Factor Receptor Treatment ...ASCO Publications

ascopubs.org

von S Boeck · · Zitiert von: 9 — Anti–Epidermal Growth Factor Receptor Treatment Strategies in Advanced Pancreatic Cancer: Success or Failure? Authors: Stefan Boeck and Volker HeinemannAuthors ... von S Boeck · · Zitiert von: 9 — Anti–Epidermal Growth Factor Receptor Treatment Strategies in Advanced Pancreatic Cancer: Success or Failure? Authors: Stefan Boeck and Volker HeinemannAuthors ...